HAMLET PROTEIN has appointed a new vice president to lead its successful research and development activities.
Katrine Hvid Ellegaard takes over the top-tuned R&D programme that has made HAMLET PROTEIN a respected player in the field of efficient, speciality ingredients for animal feed.
The appointment is another step in a planned generational change. Katrine Hvid Ellegaard will assume R & D responsibilities from company founder Ole Kaae Hansen, who remains business development director and member of the board. In addition to supporting the new vice president, he will continue to be involved in new ventures and other management tasks. Our R & D Manager, Tommas Neve shall hereafter report to Katrine Hvid Ellegaard.
With many years of experience in all aspects of R&D and Master degrees in biotechnology and change management, Katrine Hvid Ellegaard brings valuable skills to the company.
Welcoming the appointment, CEO Søren Munch says: “From the very beginning, ongoing R&D has been an integral part of our company concept. The increased global attention on sustainable high quality proteins opens up for new opportunities which we shall pursue in order to stay ahead of the competition. Katrine has all the right qualities to bring our R&D forward.”
For more information, contact CEO Søren Munch, tel: +45 7563 1020, email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it.
